Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients

NCT00292526 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT00292526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00292526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients
Lead sponsor
European Institute of Oncology
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2000
Completion date
November 30, 2011
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiotoxicity, chemotherapeutic toxicity